China Traditional Chinese Medicine Holdings Co. Limited (00570.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 1.07

From 52W high−52.90%

Volume44.19M

Market capHKD 6.14B

P/E (TTM)—

P/S (TTM)0.4x

Div yield—

Key dataSep 18, 2026

Open

HKD 1.07

From 52W high

−52.90%

Volume

44.19M

Market cap

HKD 6.14B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

3.9x

P/E (TTM)

—

RSI (14)

22.4

MomentumView details →

1D Return

−2.79%

YTD Return

−41.63%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

3.9x

EV/Sales

0.4x

P/S (TTM)

0.4x

P/B (TTM)

0.3x

ProfitabilityView details →

Gross Margin

47.46%

Net Margin

−7.91%

EBITDA Margin

9.21%

ROE (TTM)

−5.08%

ROA (TTM)

−3.35%

Asset Turnover

0.41x

GrowthView details →

Revenue YoY

−18.88%

EPS YoY

—

FCF YoY

+104.07%

Revenue CAGR 3Y

+1.02%

EPS CAGR 3Y

—

EBITDA YoY

−28.83%

MomentumView details →

1D Return

−2.79%

YTD Return

−41.63%

1Y Return

−44.55%

RSI (14)

22.4

vs 50D SMA

−12.14%

vs 200D SMA

−30.30%

Capital & dividendView details →

Debt/Equity

0.07x

Current Ratio

2.76x

Quick Ratio

2.13x

Div Yield

—

Div Rate

—

Div Growth 1Y

+66.99%

EarningsView details →

EPS (Actual)

−HKD 0.18

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

28.23B

Net Income (TTM)

−1.26B

Op. CF (TTM)

1.36B

Next earningsMar 19, 2027 →

Latest newsMore news →

China Traditional Chinese Medicine Holdings announced that its subsidiary Tongjitang Pharmaceutical's Class 1.1 innovative traditional Chinese medicine drug Xingpi Jieyu Tablets (formerly Yusuda Tablets) has been approved for market launch by the National Medical Products Administration.16d ago

China Traditional Chinese Medicine Holdings Co Ltd (00570) released its interim results for the six months ended June 30, 2026, reporting a net loss attributable to shareholders of RMB 776 million, a year-on-year increase of 619.3%, and revenue of RMB 5.438 billion, down 27.1% year-on-year.23d ago

Similar companies

China Shineway Pharmaceutical Group Limited02877.HK 辰欣药业603367.SH 昆药集团600422.SH Amneal Pharmaceuticals, Inc.AMRX CanSino Biologics Inc.06185.HK 华纳药厂688799.SH Find similar companies →

Latest newsMore news →

China Traditional Chinese Medicine Holdings announced that its subsidiary Tongjitang Pharmaceutical's Class 1.1 innovative traditional Chinese medicine drug Xingpi Jieyu Tablets (formerly Yusuda Tablets) has been approved for market launch by the National Medical Products Administration.16d ago China Traditional Chinese Medicine Holdings Co Ltd (00570) released its interim results for the six months ended June 30, 2026, reporting a net loss attributable to shareholders of RMB 776 million, a year-on-year increase of 619.3%, and revenue of RMB 5.438 billion, down 27.1% year-on-year.23d ago